A pill to treat peanut allergies is getting closer to reality — but a new study shows the drug can have some harsh side effects (AIMT, DBVT)
|11/19/2018||Posted by BusinessMediaguide.Com under General World News||
- Researchers are working on new medications to treat allergies by targeting the body’s immune system.
- According to data published Sunday in the New England Journal of Medicine, biotech company Aimmune found that after a year on its a peanut allergy treatment, 67% of kids with high peanut allergies were able to tolerate about two peanuts, compared to only 4% of those who got the placebo.
- But the path wasn’t easy. The majority of trial participants who received the drug experienced some sort of reaction, and in 14% of those cases, the reaction was severe enough to require the use of epinephrine, read more >>>